Cargando…
Peptide and Peptide-Like Modulators of 20S Proteasome Enzymatic Activity in Cancer Cells
The involvement of the ubiquitin–proteasome pathway in the degradation of critical intracellular regulatory proteins suggested a few years ago the potential use of proteasome inhibitors as novel therapeutic agents being applicable in many different disease indications, and in particular for cancer t...
Autor principal: | García-Echeverría, Carlos |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Kluwer Academic Publishers
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710986/ https://www.ncbi.nlm.nih.gov/pubmed/19617921 http://dx.doi.org/10.1007/s10989-005-9001-4 |
Ejemplares similares
-
New Peptide-Based Pharmacophore Activates 20S Proteasome
por: Osmulski, Paweł A., et al.
Publicado: (2020) -
Synthesis and SAR Study of Novel Peptide Aldehydes as Inhibitors of 20S Proteasome
por: Ma, Yuheng, et al.
Publicado: (2011) -
Proline- and Arginine-Rich
Peptides as Flexible Allosteric
Modulators of Human Proteasome Activity
por: Giżyńska, Małgorzata, et al.
Publicado: (2018) -
Decreased proteasomal cleavage at nitrotyrosine sites in proteins and peptides
por: Ott, Christiane, et al.
Publicado: (2021) -
Structure of the reduced microsporidian proteasome bound by PI31-like peptides in dormant spores
por: Jespersen, Nathan, et al.
Publicado: (2022)